Shizuoka, Japan

Takehiro Koshio

This inventor holds 1 USPTO granted patent. Top assignee: Asahi Kasei Kogyo Kabushiki Kaisha. Active years: 1993.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takehiro Koshio: Innovator in Pharmaceutical Chemistry

Introduction

Takehiro Koshio is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic potential. His work focuses on enhancing the efficacy of existing drugs while minimizing their side effects.

Latest Patents

Koshio holds a patent for a compound known as 6'-deoxy-6'-halo-neplanocin A and its production. This compound is characterized by the formula wherein A is adenine-9-yl and X is halogen, preferably iodine, or a pharmaceutically acceptable salt thereof. It represents a novel derivative of neplanocin A, exhibiting a similar level of cytotoxic activity while remaining unaffected by the action of adenosine deaminase. The production process involves replacing a hydroxyl group at position-6' in neplanocin A or 2', 3'-O-protected neplanocin A with halogen using a halogenating agent, followed by the removal of protective groups if necessary.

Career Highlights

Koshio is associated with Asahi Kasei Kogyo Kabushiki Kaisha, a leading company in the chemical and pharmaceutical industry. His work at the company has allowed him to explore innovative solutions in drug development and contribute to advancements in medical science.

Collaborations

Koshio has collaborated with notable colleagues such as Satoshi Shuto and Takumi Obara. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical research.

Conclusion

Takehiro Koshio's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in drug development. His patented work on 6'-deoxy-6'-halo-neplanocin A showcases his commitment to advancing medical science and improving therapeutic options.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…